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Abstract This study evaluates the ability of label-free fluo-
rescence lifetime imaging (FLIm) to complement intravascu-
lar ultrasound (IVUS) for concurrent visualization of human
coronary vessel composition, structure, and pathology. Co-
registered FLIm and IVUS data from 16 coronary segments
were correlated to eight distinct pathological features includ-
ing thin-cap fibroatheroma (TCFA). The sensitivity, specific-
ity, and positive predictive value for combined FLIm-IVUS
(89, 99, 89%) were better than FLIm (70, 98, 88%) and IVUS
(45, 94, 62 %) alone in distinguishing between pathologies.
FLIm can assess compositional changes in luminal surface
through variations in fluorescence lifetime values (<3.5 ns
for lipid-rich areas; >4 ns for collagen-rich areas) enabling
detection of macrophages in fibrous caps (sensitivity, 86 %)
and distinguishing between relatively stable thick-cap
fibroatheromas and rupture-prone TCFA (sensitivity, 80 %)
amongst other features. Current results demonstrate the poten-
tial of FLIm-IVUS as a new intravascular method for
improved evaluation of plaques that may subsequently aid in
guiding coronary intervention.
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Introduction
Majority of sudden acute cardiovascular events are caused due
to rupture or erosion of vulnerable plaques [1]. The identifi-
cation of these plaques can aid in the advancement of inter-
ventional techniques and pharmacological therapies to reduce
such events. Since angiography provides limited information
about the nature of the plaque occluding a vessel, percutane-
ous coronary interventions (PCIs) assisted with imaging tech-
niques have been realized as an important tool for studying
plaque progression and pathology in animals in vivo and
in patients.
Optical coherence tomography (OCT) and intravascular
ultrasound (IVUS) are the two most common intravascular
imaging techniques used in the catheterization laboratory [2]
with near-infrared spectroscopy (NIRS) recently introduced
into clinical practice as well [3]. IVUS is not able to detect
rupture-prone thin-cap fibroatheromas (TCFAs) due to limited
spatial resolution (>100 μm). Conversely, OCT has a spatial
resolution of 10–20 μm and can detect thin caps [4] as well as
assess inflammation [5] but has limited imaging penetration
depth and cannot reliably determine the size of deep plaque
cores or outward remodeling, an important indicator of plaque
vulnerability. NIRS has the ability to detect lipid cores but has
limited sensitivity for other proteins of interest such as colla-
gen and elastin. A comparison of these techniques is illustrat-
ed in Table T1 in the supplemental material. Since each mo-
dality by itself is limited in one way or another, multimodal
imaging where two or more modalities complement one an-
other to allow simultaneous assessment of plaque structure
and composition would be extremely beneficial.
The overall objective of this study is to demonstrate the
following: (1) imaging results from diseased human coronary
vessels using a novel label-free bimodal intravascular scan-
ning technique that combines fluorescence lifetime imaging
(FLIm) and IVUS and (2) the ability of FLIm to complement
conventional IVUS for improved human coronary plaque as-
sessment via quantification of plaque composition. Previous
work has shown the potential of endogenous fluorescence
lifetime measurements for atherosclerotic plaque characteriza-
tion in open arteries [6, 7]. This paper reports the first results
from human coronary arteries interrogated with such a bimod-
al rotational catheter that serves as an important feasibility step
prior to studying plaques in an in vivo animal model as well as
future human studies. We explore the ability of FLIm in de-
tecting biochemical features (e.g., infiltration of macrophages
in fibrous caps) and distinguishing between rupture-prone
thin-cap fibroatheromas (TCFAs) from relatively stable
thick-cap fibroatheromas (ThCFAs) that can complement
morphological features derived from conventional IVUS.
Methods
Specimens
The human left anterior descending (LAD) coronary artery
samples used in these studies were obtained from 16 different
patients from the University of Pennsylvania with approval
from the institutional review board (additional information
in the supplemental material). Samples were chilled in
isopentane and rapidly frozen in liquid nitrogen and shipped
overnight and stored at −80 °C.
FLIm-IVUS Imaging Studies
The FLIm-IVUS bimodal imaging system and rotational cath-
eter (5-Fr shaft and 3-Fr imaging section) used in this study
have been previously described in detail [8] and can perform
sequential IVUS and FLIm helical scans. Details of the FLIm
subsystem are described in the supplemental material. Briefly,
it is composed of a 300-μm core ultraviolet (UV)-grade silica/
silica side-viewing optical fiber (Polymicro, Phoenix, AZ) ro-
tating at 1200 rpm delivering UV light (Fianium, 355 nm, 80-
ps pulse width) with a repetition rate of 10 KHz and an energy
of ~100 nJ/pulse. The IVUS subsystem (Atlantis SR Pro with
iLab, Boston Scientific, MA, USA) is composed of a single
element transducer (40 MHz) driven at a rotation speed of
1800 rpm with data sampled at 200 MHz. Both FLIm and
IVUS imaging were performed with a pullback speed of
2 mm/s sequentially. FLIm had an axial/angular resolution
of 160 μm/14° while IVUS had an axial/lateral resolution of
100 μm/200 μm. A 20-mm pullback took 10 s for each mo-
dality. Data acquisition, saving, and processing took 6 min in
total [8]. FLIm-IVUS co-registration was performed offline.
The specimen was imaged in a custom-built holder placed
in a phosphate-buffered saline bath maintained at 37 °C. The
specimen was fastened on to luers that presented a notch
painted with fluorescent ink so that they were visible on both
FLIm and IVUS images to allow axial and angular co-
registration of both modalities (Fig. S1 in the supplemental
material). Additionally, a guide wire (0.014″) was also placed
in the lumen that was visible on both modalities to aid in
angular registration. The guide wire was immobilized by fas-
tening it in place using the screw end of the luer receiver
(Fig. S1c in the supplemental material). It must be noted that
FLIm-IVUS imaging was performed in saline and not blood.
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In vivo FLIm imaging will require clearance of blood as is
done during OCT imaging. Tissue processing for acquiring
co-registered histology is detailed in the supplemental materi-
al. A total of 87 histological sections were cut at 2-mm inter-
vals from all specimens. For each cut, FLIm-IVUS data were
averaged from the corresponding registered frame and the two
adjacent frames. All histology slides were digitized at ×20
magnification (Aperio ScanScope, Aperio Technologies) for
morphometric analysis.
Pathological Features and Morphometric Analysis
Eight different pathological features were characterized in this
study (Table 1) following definitions published by Virmani
et al. [9]. Representative histology images for various features
are shown in Fig. S2 in the supplemental material. On the
digitized histology images, these features were identified by
a pathologist as regions of interest (ROIs). Characteristic de-
scriptors such as the amount of collagen, elastin, lipids/cho-
lesterol, calcium, smooth muscle cells, and macrophages/
lymphocytes were observed on pathology that allowed
assigning a given ROI to one of the eight features.
Significant macrophage/lymphocyte infiltration in tissue was
determined by identifying the presence of >10 % clusters of
differentiation (CD) 68+/CD45+ staining area in a given ROI.
ROI selection and measurement of fibrous cap thickness were
performed using a commercial software (Aperio ImageScope,
Aperio Technologies). Corresponding co-registered imaging
data were extracted by defining the same ROI on IVUS im-
ages. FLIm data were mapped onto the IVUS lumen [10] and
attributed to the corresponding ROI. The ROIs on IVUS were
scaled up in size proportional to the change in the scale bars
between IVUS and histology when both images were co-reg-
istered. This change in ROI size between IVUS and histology
is due to shrinkage in tissue after histological processing.
Imaging Parameters
A total of five IVUS-derived parameters and 42 FLIm-derived
parameters were studied. The IVUS parameters included log-
compressed ultrasound intensity (UI), integrated backscatter
(IB) values, energy norm (E), intimal thickness (IT), and radial
distance (R) of the ROI from the center of the IVUS transduc-
er. The computation of these parameters have been previously
reported [11] and are described in detail in the supplemental
material. UI, IB, and E represent the amount of sound
backscattered from tissue and may allow differentiating be-
tween different tissue types.
FLIm data includes fluorescence measurements from three
sub-bands with central wavelength/bandwidth of 390/40 nm
(channel 1 (CH1)), 452/45 nm (channel 2 (CH2)), and 542/
50 nm (channel 3 (CH3)), respectively. CH1 encompasses
fluorescence predominantly from collagen, CH2 from elastin
and NADH, and collagen and CH3 from lipids and lipopro-
teins. The FLIm parameters included intensity ratios from
channels (CH1/CH2, CH2/CH3, and CH1/CH3), average life-
time values, and the 12 Laguerre coefficient values from each
of the channels CH1, CH2, and CH3. The analysis of raw
FLIm data for the computation of the aforementioned FLIm
parameters has been described in detail previously [12] and is
briefly summarized in the supplemental material. The pene-
tration of UV light in tissue is limited to 200–250 μm [13, 14].
As a result, FLIm parameters are not defined for deep lipid-
rich core of a fibroatheroma (LFA).
Statistical Analysis
FLIm-IVUS data from ROIs were fitted to a linear
mixed effects model [15] to determine statistically sig-
nificant correlations between various imaging parameters
and pathological features. Statistically significant imag-
ing parameters (p<0.05) were used to train a support
vector machine (SVM) classifier between different path-
ological features. A leave-one-out cross-validation test
was performed to determine the sensitivity, specificity,
and positive predictive value of FLIm, IVUS, and
FLIm-IVUS parameters of detecting the eight patholog-
ical conditions over the entire data set. Details of the
statistical analysis are summarized in the supplemental
material.
Results
Table 1 summarizes all the pathological features identified in
this study along with the number of ROIs attributed to each
feature from the 16 human LAD coronary specimens.
FLIm-IVUS Data Visualization
An example of three-dimensional (3-D) visualization of co-
registered FLIm (CH1 data) and IVUS data from a coronary
specimen highlighting different morphological and biochem-
ical features is shown in Fig. 1 (Video1.avi in the
supplemental material). Such representation of the arterial
vessel can aid the physician in the detection of different plaque
types by allowing simultaneous visualization of such compli-
mentary features in a clinical setting. Changes in fluorescence
lifetime values have been attributed to changes in collagen,
lipid, and macrophage content [6, 7] and are confirmed in
images shown in Fig. 2 and data summarized in Figs. 3 and
4. This information, coupled with morphological features
from IVUS such as IT, hyperechoic calcified tissue, and
hypoechoic lipid cores, allows identification of relevant pa-
thology described in Table 1.
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FLIm-IVUS Data and Pathology
Co-registered FLIm-IVUS images and histopathology data
depicting different pathological features are shown in Fig. 2.
Figures 3 and 4 summarize distributions of select statistically
significant imaging parameters in relation to the pathological
features. Data in this section are reported as mean±SD along
with confidence intervals at 99 % confidence level. Figure 2a
shows a case with diffuse intimal thickening (DIT).
Fluorescence lifetime values are seen to be uniform (CH1
lifetime for entire data set for DIT, 3.71±0.34 ns (3.71–
3.72 ns)) over the entire lumen surface with IVUS showing
narrow to no intimal thickening. Figure 2b shows a case with
ThCFA and LFA. A thick fibrous cap is seen in IVUS (small
arrow), and lifetime values in this region are higher (CH1
lifetime for entire data set for ThCFA, 4.27±0.33 ns (4.25–
4.28 ns)) due to increase in collagen content as seen in histo-
pathology. LFA (large arrow) is seen on IVUS as hypoechoic
region (IB for entire data set for LFA, −80.2±3.4 dB (−80.3–
−80.2 dB)). Figure 2c shows a case with pathological intimal
thickening (PIT, small arrow) and fibrocalcific plaque (FC,
large arrow). PIT is seen with larger intimal thickening in
IVUS and has higher average fluorescence lifetime (CH2 life-
time for entire data set for PIT, 4.28±0.19 ns (4.28–4.30 ns))
compared to DIT (Fig. 4). FC is seen as hyperechoic region in
IVUS (IB for entire data set for FC, −57.5±6.6 dB (−57.6–
−57.5 dB)) with loss of signal and shadowing behind the area
of interest. The amount of fibrous tissue present in FC can be
correlated to an increase in overall lifetime similar to PIT.
However, FLIm alone is not able to distinguish between FC
and fibrotic tissue (FT) due to similar collagen content, but the
two features can be differentiated using IVUS (Fig. 4).
Figure 2d shows a case with TCFA (both arrows) with
intraplaque hemorrhage (large arrow). The spatial resolution
of IVUS does not allow visualization of the thin cap.
However, there is a significant decrease in fluorescence life-
time values in both regions (CH1 lifetime for entire data set for
TCFA, 3.44±0.44 ns (3.41–3.47 ns)) due to low collagen
content and high lipid and macrophage content (CD68 stained
pathology not shown). Intraplaque hemorrhage is often ob-
served as low-echoic region in IVUS and may be confused
with LFA. Figure 2e shows a case with FC which correlates to
high backscatter signal in IVUS (arrow). CH1 lifetime values
are higher than those observed in DIT (CH1 lifetime for entire
data set for FC, 3.98±0.39 ns (3.96–3.99 ns)). Figure 2f shows
a case with FT and DIT where the region with FT has higher
average lifetime values (CH1 lifetime for entire data set for
FT, 4.19±0.29 ns (4.17–4.20 ns)) than DIT. IVUS can distin-
guish between DIT and FT based on IT but not backscatter
data alone (Fig. 4). Figure 2g shows a case with ThCFAM and
LFA. Lowering of lifetime values is seen in the region infil-
trated bymacrophages (small arrow) as confirmed on a CD68-
stained histopathology section (CH1 lifetime for entire data
set for ThCFAM, 3.49±0.71 ns (3.44–3.55 ns)). IVUS is not
able to detect the presence of macrophages in fibrous caps but
allows visualization of the plaque burden underneath (large
arrow). Distributions for select FLIm and IVUS imaging pa-
rameters (post hoc Tukey’s test p<0.001, as shown in Fig. 3)
illustrate the ability of FLIm to distinguish between ThCFA
and TCFA and detecting the presence of macrophages in fi-
brous caps (ThCFA vs. ThCFAM). These results (Figs. 3 and
4) emphasize that IVUS and FLIm together allow
Fig. 1 FLIm-IVUS data
visualization. a CH1 fluorescence
lifetime values mapped on to 3-D
lumen surface. Three co-
registered IVUS frames are
shown. b Longitudinal IVUS
image with CH1 fluorescence
lifetime values mapped on to the
lumen surface. Lower lifetime
values indicate the presence of
macrophages and lipid in plaque
while higher lifetime values relate
to increased collagen content.
IVUS allows identification of
calcium and lipid cores based on
high and low echogenicities,
respectively
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distinguishing between fibrolipidic plaques (TCFA, ThCFA,
ThCFAM) from stable fibrous plaques (PIT, FT). Distribution
of different imaging parameters across all pathological fea-
tures can be appreciated from Fig. 4. A total of 47 imaging
parameters (5 from IVUS and 42 from FLIm) were investigat-
ed for statistical significance. Of these, 39 were found to be
able to distinguish between at least a pair of pathological fea-
tures if not more. We show a select set of parameters (Figs. 3
and 4) that show the ability of FLIm and IVUS to distinguish
between all the different pathological features. However, all
the 39 statistically significant parameters were employed to
train an SVM classifier.
Fig. 2 Representative images of co-registered IVUS, FLIm, and histol-
ogy data showing different pathological features. Lifetime values (in ns)
mapped onto the lumen surface are either from CH1 or CH2. Guide wire
artifact is highlighted with a red asterisk. a DITwith uniform distribution
of lifetime values over the lumen surface. IVUS shows minimal intimal
thickening. b ThCFA and LFA. The thick cap (small arrow) is seen on
both histology and IVUSwith an underlying lipid-rich core (large arrow).
Lifetime values at the cap region are higher due to increased amount of
fibrous collagen. c PIT (small arrow) and FC (large arrow) are seen with
varying echogenicities on IVUS as well as different lifetime values. d
TCFA with intraplaque hemorrhage is seen with distinct lowering in
lifetime values (arrows). IVUS is able to show burden of the TCFA core.
e FC (arrow) is seen on IVUS as a region of high backscatter with a
shadow. f FT is seen (small arrow) with increased lifetime values due
to increase in collagen content as compared to regions with DIT (large
arrow). g ThCFAM is seen with a fibrous cap (small arrow) rich in
macrophages as confirmed in CD68-stained section (middle) along with
CD45-stained section (right). Lipid-rich core (large arrow) is also seen on
both IVUS and histology. Lowering in lifetime values is observed over
the fibrous cap rich in macrophages compared to the surrounding regions
in the lumen. Scale bars (red) on IVUS are 1 mm, and scale bars on
histology (black) are 0.5 mm
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Fig. 3 FLIm and IVUS
parameter distribution for
different pathology feature pairs.
Parameters shown here are few of
many that were found to be
statistically different (post hoc
Tukey’s test p<0.001) between
the pairs of pathological features
(described in Table 1)
Fig. 4 Box-whisker plots of select FLIm and IVUS parameters across all
pathological features (described in Table 1). The red bars represent the
median value, the edges of the blue box are the 25th and 75th percentiles,
the whiskers extend to 1.5 times the blue box height, and outliers are
plotted as red dots. Each box is labeled with one or more letters (a, b,
c, or d). Boxes sharing no common letter are statistically different from
one another (post hoc Tukey’s test p-value printed on upper right corner
of each plot). Numerous other parameters were found to be able to
discriminate between different pathological features; however, only a
few parameters are shown here. No FLIm data are available for LFA
due to limited penetration of UV light in tissue (200–250 μm). These
parameters along with others (not shown) allow discriminating between
any given pair of pathological features
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Classification Results
Classification results are summarized in Table 2. A total of
184 ROIs attributed to different pathological features were
used in the analyses. Thirty-nine of the 42 imaging parameters
that were statistically significant (mixed effects ANOVA,
p<0.05, post hoc Tukey’s test, p<0.05) were used to train
SVM classifiers from FLIm, IVUS, and FLIm-IVUS data,
respectively. Figure 5 shows 3-D scatter plots showing the
data and the SVM classifier hyperplane for two features:
ThCFA and DIT. The plots show an SVM built using three
parameters; however, the overall classification was performed
using SVMs built with all the statistically significant parame-
ters. The plots illustrate the improvement in sensitivity when a
classifier is trained using both IVUS and FLIm parameters as
opposed to one or the other alone.
IVUS imaging allowed reliable detection of FC and LFA as
compared to FLIm alone. FLIm allowed detection of ThCFA,
ThCFAM, and TCFA as observed from parameter distributions
in Figs. 3 and 4. The sensitivity of detecting ThCFA and
ThCFAM improved when both FLIm and IVUS data are used
as compared to FLIm alone due to IT information available
from IVUS. The classifier trained using FLIm parameters does
not include the feature LFA, as no FLIm data are available for
this feature due to limited penetration of UV light in tissue. As a
result, the FLIm classifier appears to have better performance
than the FLIm-IVUS classifier for certain features.
Discussion
This study demonstrates for the first time that FLIm, a label-
free spectroscopic rotational intravascular imaging technique,
can complement morphological information from convention-
al IVUS with compositional information from the sub-intimal
surface. FLIm-IVUS results from human LAD coronary arter-
ies show the ability of this bimodal approach to detect differ-
ent pathological features (Table 1) that are a subset
of the modified classification scheme of Virmani et al. for
atherosclerotic lesions [9]. Specifically, results (Figs. 3 and
4) show that FLIm allows differentiating between luminal
areas histopathologically classified as TCFA from those clas-
sified as ThCFA as well as identifying macrophage infiltration
in fibrous caps (ThCFAM). The clinical importance of detect-
ing these plaque sub-types has been well emphasized [16].
Moreover, FLIm-IVUS data can be visualized concurrently
(Figs. 1 and 2 and Video1.avi in the supplemental material)
to comprehend both luminal composition and morphology of
vessels simultaneously for enhanced plaque characterization
that may serve as an invaluable tool to study plaque
progression.
Compositional changes in tissue can be tracked by quanti-
fying the autofluorescence of tissue components [17]. In this
work, FLIm quantifies changes in fluorescence decay dynam-
ics (e.g., average lifetime values and Laguerre coefficients) as
a function of changes in arterial tissue composition (e.g., col-
lagen, elastin, and lipids including cholesteryl oleate in mac-
rophages). Thus, the accumulation of macrophages in the fi-
brotic cap and the co-localization of lipids change the overall
fluorescence signature measured from tissue. While these
compositional changes can only be assessed within 200–
250 μm deep into the plaque due to limited penetration of
UV light in tissue [13, 14], they provide valuable information
about features in the diseased intima that have been associated
with plaque instability and rupture. More importantly, for a
plaque with a thick cap (ThCFA), FLIm will only be able to
Table 2 Classification results summary
Feature IVUS FLIm FLIm-IVUS
SN (%) SP (%) PPV (%) SN (%) SP (%) PPV (%) SN (%) SP (%) PPV (%)
DIT 81 81 71 100 96 93 87 100 100
PIT 50 84 40 94 98 91 84 100 100
ThCFA 29 99 80 57 100 100 86 100 100
ThCFAM 0 100 NaN 71 100 100 86 100 100
TCFA 0 100 NaN 90 100 100 80 100 100
FC 100 99 97 44 99 94 100 99 97
FT 0 100 NaN 100 90 40 92 99 92
LFA 100 91 19 0.0 100.0 NaN 100 92 21
Mean 45 94 61 70 98 88 89 99 89
DIT diffuse intimal thickening, PIT pathological intimal thickening, ThCFA thick-cap fibroatheroma, ThCFAM thick-cap fibroatheroma with
macrophage/lymphocyte infiltration in cap, TCFA thin-cap fibroatheroma, FC fibrocalcific plaque, FT fibrotic tissue, LFA lipid-rich core of
fibroatheroma, SN sensitivity, SP specificity, PPV positive predictive value, IVUS intravascular ultrasound, FLIm fluorescence lifetime imaging, NaN
not a number (corresponds to division by zero)
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gather information from the cap and not from the underlying
core. However, for caps that are relatively thin, such as in a
TCFA (<65 μm), FLIm data will include information from
both cap and part of the underlying core. Hence, despite the
limited penetration depth of UV light, the ability of FLIm to
resolve compositional changes in tissue makes it possible to
identify TCFA from other plaque sub-types and detect macro-
phage infiltration (ThCFAM)—features that cannot be detect-
ed by IVUS alone.
In general, CH1 lifetime values are lowered due to the
presence of macrophage and lipids, as well as due to reduction
in collagen content as observed in data shown in Fig. 4. CH2
lifetime values can differentiate between ThCFA and TCFA
while CH3 lifetime values can differentiate between ThCFAM
and ThCFA (Fig. 4). IVUS provides morphological informa-
tion such as intimal thickening, plaque burden, and presence
of calcification that complements FLIm data for enhanced
detection of different histologic subtypes in diseased coronary
arteries. Besides possibly detecting vulnerable plaques, FLIm-
IVUS imaging enables distinguishing between fibrous stiff
plaques (FC, FT, and PIT) and lipid-rich plaques (TCFA,
ThCFA, and ThCFAM) that may be important during PCI.
Qualitative results shown in Fig. 2 also illustrate the com-
bined value of FLIm-IVUS imaging. Different plaque sub-
types that cannot be distinguished by IVUS or FLIm alone
are discerned by FLIm-IVUS synergism. SVM-based classi-
fication results also underscore the benefit of bimodal FLIm-
IVUS arterial vessel evaluation (Table 2 and Fig. 5).
It is arguable that all eight different pathological features
included in this study may not be relevant to a physician in a
clinical setting. However, this study aims to highlight the sen-
sitivity of our technique in relation to pathology that may be
important for our ongoing research and studying plaque
pathology.
Study Limitations
Current configuration of the intravascular catheter and system
requires that the FLIm-IVUS data be gathered sequentially
rather than simultaneously. Thus, data acquisition and pro-
cessing is rather long (~6 min). The use of graphics processing
units to perform the same task can significantly reduce this
time to allow real-time analysis (<1 min) in our future system.
Moreover, our new catheter under development enables si-
multaneous FLIm-IVUS imaging by integrating the fiber optic
and transducer on the same rotational axis. The registration
error between FLIm and IVUS in the current study due to
sequential imaging was found to be ~18° from phantom im-
aging experiments. As a result, ROIs defined by the patholo-
gist that were less than 30° in span were not used in the study.
However, this error will be avoided for future studies using the
new catheter design.
Coronary segments in this study were imaged in saline and
not in blood. In vivo imaging, however, will be performed by
clearing the vessel of blood as is done during OCT imaging.
Potential inadequate flushing or presence of blood may affect
the FLIm spectroscopic findings which need to be quantified
in future in vivo testing of this technique. Current work in
progress is investigating flushing techniques to acquire
FLIm-IVUS images in vivo in a pig using the new catheter
system noted above. Flushing-related complications such as
arrhythmia and hypotension that may arise will be addressed
by developing a custom IVUS system to increase the pull-
back speed and reduce flushing times. The limited penetration
of UV light in tissue confines the ability of FLIm to interrogate
only the biochemical composition of the luminal surface of the
arterial wall. However, the compositional information gath-
ered from this region is seen to be beneficial in
complementing morphological data from IVUS in this study.
Fig. 5 Three-dimensional scatter plots of training data for ThCFA and
DIT using parameters from a IVUS, b FLIm, and c both FLIm and IVUS.
Three imaging parameters were used for plotting purposes although up to
39 were used for the overall classification study. The SVM classifier
hyperplane (gray) acts as a decision boundary for classification
purposes. ThCFA detection sensitivity (reported in parenthesis)
improves when both FLIm and IVUS parameters are used, enforcing
the benefit of a bimodal imaging technique
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Relative comparison of performances of various intravascular
imaging techniques is shown in Table T1 in the supplemental
material. The spatial resolution of FLIm used in this study is in
the order of hundreds of microns (160 μm) but proves to be
sufficient for imaging luminal surface features.
Conclusions
This article reports the first results demonstrating the feasibil-
ity of a bimodal label-free tissue diagnostic technique com-
bining rotational FLIm and IVUS for intravascular assessment
of human coronary plaques. Current results demonstrate that
FLIm technique can complement conventional IVUS and en-
able a better detection of various relevant pathological features
that cannot be detected by IVUS alone. FLIm, through chang-
es in tissue lifetime values, is capable of detecting the presence
of macrophages in fibrous caps which is a prognostic factor
for vulnerable plaques. It can also distinguish between TCFA
and ThCFA amongst other pathological features. The changes
in lifetime values are attributed to changes in lipid, macro-
phage, and collagen content in the intima. FLIm results
coupled with morphological information from IVUS create a
robust tool for staging plaques in arterial vessels. FLIm-IVUS
bimodal data can be visualized in a clinical setting in 3-D or as
cross-sectional images to aid the physician in the decision-
making process during PCI. Results from this study lay the
foundation for the future clinical applicability of FLIm-IVUS
imaging to characterize plaques in vivo in real time, initially in
a pig atherosclerotic model and, subsequently, in humans.
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